143 related articles for article (PubMed ID: 27919967)
1. Epithelial-Mesenchymal Expression Phenotype of Primary Melanoma and Matched Metastases and Relationship with Overall Survival.
Yan S; Holderness BM; Li Z; Seidel GD; Gui J; Fisher JL; Ernstoff MS
Anticancer Res; 2016 Dec; 36(12):6449-6456. PubMed ID: 27919967
[TBL] [Abstract][Full Text] [Related]
2. Role of epithelial-mesenchymal transition involved molecules in the progression of cutaneous melanoma.
Murtas D; Maxia C; Diana A; Pilloni L; Corda C; Minerba L; Tomei S; Piras F; Ferreli C; Perra MT
Histochem Cell Biol; 2017 Dec; 148(6):639-649. PubMed ID: 28828681
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of E-cadherin and N-cadherin expression in Gliomas.
Noh MG; Oh SJ; Ahn EJ; Kim YJ; Jung TY; Jung S; Kim KK; Lee JH; Lee KH; Moon KS
BMC Cancer; 2017 Aug; 17(1):583. PubMed ID: 28851312
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility.
Stoyianni A; Goussia A; Pentheroudakis G; Siozopoulou V; Ioachim E; Krikelis D; Golfinopoulos V; Cervantes A; Bobos M; Fotsis T; Bellou S; Fountzilas G; Malamou-Mitsi V; Pavlidis N
Anticancer Res; 2012 Apr; 32(4):1273-81. PubMed ID: 22493359
[TBL] [Abstract][Full Text] [Related]
5. Differential membranous E-cadherin expression, cell proliferation and O-GlcNAcylation between primary and metastatic nodal lesion in colorectal cancer.
Jang TJ
Pathol Res Pract; 2016 Feb; 212(2):113-9. PubMed ID: 26724145
[TBL] [Abstract][Full Text] [Related]
6. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C inhibitor Gö6976 but not Gö6983 induces the reversion of E- to N-cadherin switch and metastatic phenotype in melanoma: identification of the role of protein kinase D1.
Merzoug-Larabi M; Spasojevic C; Eymard M; Hugonin C; Auclair C; Karam M
BMC Cancer; 2017 Jan; 17(1):12. PubMed ID: 28056869
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells.
Sun T; Jiao L; Wang Y; Yu Y; Ming L
Cell Death Dis; 2018 Jan; 9(2):136. PubMed ID: 29374154
[TBL] [Abstract][Full Text] [Related]
9. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
10. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of epithelial-mesenchymal transition-related markers between cancer tissue and tumor emboli].
He N; Wu GF; Zhao HY; Han HX
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):758-61. PubMed ID: 22336160
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas.
Attis MG; Burchette JL; Selim MA; Pham T; Soler AP
Hum Pathol; 2006 Jul; 37(7):899-905. PubMed ID: 16784991
[TBL] [Abstract][Full Text] [Related]
13. E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression.
Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
Br J Dermatol; 2013 Sep; 169(3):618-28. PubMed ID: 23662813
[TBL] [Abstract][Full Text] [Related]
14. FOXC2 expression and epithelial-mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer.
Børretzen A; Gravdal K; Haukaas SA; Beisland C; Akslen LA; Halvorsen OJ
J Pathol Clin Res; 2019 Oct; 5(4):272-286. PubMed ID: 31464093
[TBL] [Abstract][Full Text] [Related]
15. Desmoplastic melanoma: expression of epithelial-mesenchymal transition-related proteins.
Garrido MC; Requena L; Kutzner H; Ortiz P; Pérez-Gómez B; Rodriguez-Peralto JL
Am J Dermatopathol; 2014 Mar; 36(3):238-42. PubMed ID: 23974224
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2'-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma.
Hintsala HR; Haapasaari KM; Soini Y; Karihtala P
Histol Histopathol; 2017 Feb; 32(2):129-136. PubMed ID: 27170270
[TBL] [Abstract][Full Text] [Related]
17. Reacquisition of E-cadherin expression in metastatic deposits of signet-ring cell carcinoma of the upper gastrointestinal system: a potential anchor for metastatic deposition.
Ma YR; Siegal GP; Wei S
J Clin Pathol; 2017 Jun; 70(6):528-532. PubMed ID: 27864451
[TBL] [Abstract][Full Text] [Related]
18. Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation.
Seline PC; Norris DA; Horikawa T; Fujita M; Middleton MH; Morelli JG
J Invest Dermatol; 1996 Jun; 106(6):1320-4. PubMed ID: 8752677
[TBL] [Abstract][Full Text] [Related]
19. A comparison of Twist and E-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases.
Wang G; Dong W; Shen H; Mu X; Li Z; Lin X; Liu Y; Du J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):1028-32. PubMed ID: 21376622
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of cadherin-based adhesion molecules in cutaneous malignant melanoma.
Kreizenbeck GM; Berger AJ; Subtil A; Rimm DL; Gould Rothberg BE
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):949-58. PubMed ID: 18398036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
